# FDA recall D-0001-2021

> **Strides Inc.** · Class II · drug recall initiated 2020-08-24.

## Product

Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP  8mEq  (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816     NDC 64380-860-06

## Reason for recall

Failed Dissolution Specifications

## Distribution

nationwide

## Key facts

- **Recall number:** D-0001-2021
- **Recalling firm:** Strides Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-08-24
- **Report date:** 2020-10-07
- **Termination date:** 2022-01-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lambertville, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0001-2021

## Citation

> AI Analytics. FDA recall D-0001-2021. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0001-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*